Annual Meeting News

LOS ANGELES--(BUSINESS WIRE)--Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future,” “FF” or the “Company”), a California-based global Embodied AI (EAI) ecosystem company, today announced the results of its 2026 Annual Meeting of Stockholders (the “Annual Meeting”) held today, May 22nd, at which the Company’s stockholders approved all of the submitted proposals, which were meant to enhance FF’s financial stability and empower the leadership team to execute its strategic plan...

ATLANTA--(BUSINESS WIRE)--Angel Oak Financial Strategies Income Term Trust (NYSE – FINS) (the “Fund”) has closed a $50 million private offering of Series A Mandatorily Redeemable Preferred Shares, due April 30, 2031 (the “MRPS”). The MRPS are rated A3 by Moody’s Investors Service, Inc. Net proceeds from the offering of the MRPS will be used primarily to refinance the Fund's existing debt and to make new portfolio investments. In addition, the Fund has entered into a Notes Purchase Agreement in...

HALIFAX, Nova Scotia--(BUSINESS WIRE)--Emera Inc. (TSX/NYSE: EMA) announced that at its Annual Meeting of Shareholders held on May 21, 2026, on a vote by ballot, each of the 11 nominees proposed as Directors and listed in its Management Information Circular dated as of March 19, 2026 were elected as Directors. The detailed results of the vote for the election of Directors are set out below. Nominee Votes For Votes Withheld   Number Percent Number Percent Scott C. Balfour 158,298,930 99.75% 390,...

GUILFORD, Conn.--(BUSINESS WIRE)--PRIME study results show bedside portable MRI cut order-to-scan time vs conventional MRI and identified critical ED findings....

NEW YORK--(BUSINESS WIRE)--BBRC International PTE Limited (together with its affiliates, “BBRC” or “we”), a long-term stockholder of Victoria’s Secret & Co. (NYSE: VSCO) (“VS” or the “Company”) and owner of approximately 13% of the Company’s outstanding shares, today issued the following statement in response to the Company’s May 20 presentation. “Over the past year, VS has repeatedly misrepresented BBRC’s intentions while ignoring every concern we have raised regarding the Board’s slow and...

MORRISVILLE, N.C.--(BUSINESS WIRE)--SAGA will present new data supporting Pathlight, its tumor-informed, structural variant-based ctDNA platform, across metastatic and localized cancers....

MARSEILLE, France--(BUSINESS WIRE)--Outcome of Innate Pharma’s 2026 Annual General Meeting...

AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced a landmark oncology data program for the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. The meeting will take place May 29–June 2 in Chicago, IL. Together with its collaborators, Natera will demonstrate unmatched scale in evidence generation with 35 abstracts across molecular residual disease (MRD) testing and other innovations. Presentations w...

IRVINE, Calif. & AMSTERDAM--(BUSINESS WIRE)--Agendia will present two posters highlighting how its tests provide insights into treatment response and aid therapeutic decision-making for EBC....

COPENHAGEN, Denmark--(BUSINESS WIRE)--Genmab A/S (Nasdaq: GMAB) announced today that 23 abstracts, including 20 abstracts evaluating epcoritamab, a subcutaneous T-cell engaging bispecific antibody, will be presented or published at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL, from May 29-June 2, and at the European Hematology Association (EHA) 2026 Congress in Stockholm, Sweden, from June 11-14. Key presentations at ASCO and EHA will highlight data evalua...